MACROGENICS, INC. Income Taxes Paid
MACROGENICS, INC. (MGNX) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-14
- MACROGENICS, INC. income taxes paid for the quarter ending 2025-09-30 was $0.00.
- MACROGENICS, INC. income taxes paid for the quarter ending 2024-12-31 was $944.00K.
- MACROGENICS, INC. income taxes paid for the quarter ending 2024-09-30 was $0.00.
- MACROGENICS, INC. income taxes paid for fiscal 2024 was $944.00K.
- MACROGENICS, INC. income taxes paid for fiscal 2023 was $0.00.
- MACROGENICS, INC. income taxes paid for fiscal 2022 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $105.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $105.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $944.00K derived: sum of 2 quarters · filed 2025-11-12 | $944.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |